| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.044 | 0.6 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.6 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |